BHCM
ETON icon

Brevan Howard Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Brevan Howard Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Sell
7,955
-14,551
-65% -$427K ﹤0.01% 1732
2026
Q1 		$555K Buy
+22,506
New +$394K ﹤0.01% 1236
2025
Q2 		– Sell
-10,693
Closed -$139K – 1886
2025
Q1 		$139K Buy
+10,693
New +$162K ﹤0.01% 1027

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Brevan Howard Capital Management's ETON Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Eton Pharmaceutcials (ETON) stake by 65% in Q2 2026, selling an estimated $427K and leaving 7,955 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #1732.

Brevan Howard Capital Management first reported a position in ETON in Q1 2025 and has held it in 3 quarters since. The position peaked at $555K in Q1 2026. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Brevan Howard Capital Management held 7,955 shares of Eton Pharmaceutcials worth $288K as of Q2 2026.
  • Brevan Howard Capital Management sold 14,551 Eton Pharmaceutcials shares in Q2 2026, an estimated $427K.
  • Eton Pharmaceutcials made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1732 holding.
  • Brevan Howard Capital Management first reported a position in Eton Pharmaceutcials in Q1 2025 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Eton Pharmaceutcials position peaked at $555K in Q1 2026.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.